News and Events
CrossLife Tech’s IsoTARA COVID-19 Colorimetric Assay has been developed and submitted for EUA approval
June 2020 | In response to the global outbreak of COVID-19, CrossLife Technologies has developed the IsoTARATM COVID-19 Colorimetric Assay to perform near...
Read more
CrossLife Tech’s Molecular Test for the Novel Coronavirus, CLT™ SARS-CoV-2 qRT-PCR, Has Developed.
June 2020 | In response to the global outbreak of the novel coronavirus disease (COVID-19), CrossLife Technologies has developed a real-time RT-PCR test, CLT™...
Read more
CrossLife Awarded NIH SBIR II Grant for HIV Point-of-Care Diagnostic
August 2018 | CrossLife has recently been awarded a Phase II Small Business Innovative Research (SBIR) grant from NIH/NIAID for A Rapid Paper Strip Nucleic Acid Test...
Read moreWhere We Excel
RNA/DNA Molecular Diagnostics
Point-of-Care Diagnostics
Infectious Disease Detection
Key Differentiators
Minimal Sample Preparation
Amplification without PCR
Low cost
Point-of-Care
Collaborators
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
||